Baseline demographics and clinical characteristics in the all nippon af in the elderly (ANAFIE) registry

Yukihiro Koretsune, Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Takanori Ikeda, Ken Okumura, Wataru Shimizu, Hiroyuki Tsutsui, Kazunori Toyoda, Atsushi Hirayama, Masahiro Yasaka, Takenori Yamaguchi, Satoshi Teramukai, Tetsuya Kimura, Jumpei Kaburagi, Atsushi Takita, Hiroshi Inoue

Research output: Contribution to journalArticle

Abstract

Background: Despite the well-established benefits in patients with nonvalvular atrial fibrillation (NVAF), anticoagulants have been underused in elderly patients. The All Nippon AF In the Elderly (ANAFIE) Registry is a multicenter, prospective, observational study with 2-year follow-up of Japanese patients aged ≥75 years with a definitive diagnosis of NVAF, aiming to collect detailed information on clinical status and therapeutic challenges in this patient population. Methods and Results: Patients were enrolled from October 2016 to January 2018. A total of 32,726 patients (57.2% male) were included. The average age, CHADS2 score, and creatinine clearance were 81.5±4.8 years (26.2% of patients were aged ≥85 years), 2.9±1.2, and 48.4±21.8 mL/min, respectively. Paroxysmal AF was the most common clinical AF type (42.0%), and most patients (97.2%) had comorbidities. Most patients (91.9%) were receiving anticoagulant therapy; of these, 27.8% and 72.2% were treated with warfarin and direct oral anticoagulants, respectively. The average number of concomitant drugs used was 6.6±3.2, including anticoagulants. Conclusions: The ANAFIE Registry is the largest prospective registry study of elderly Japanese patients with NVAF to date. Baseline data indicate that patients in this age group are treated in a manner similar to their younger counterparts.

Original languageEnglish
Pages (from-to)1538-1545
Number of pages8
JournalCirculation Journal
Volume83
Issue number7
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Registries
Demography
Anticoagulants
Atrial Fibrillation
Prospective Studies
Warfarin
Observational Studies
Comorbidity
Creatinine
Age Groups
Therapeutics

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Koretsune, Y., Yamashita, T., Akao, M., Atarashi, H., Ikeda, T., Okumura, K., ... Inoue, H. (2019). Baseline demographics and clinical characteristics in the all nippon af in the elderly (ANAFIE) registry. Circulation Journal, 83(7), 1538-1545. https://doi.org/10.1253/circj.CJ-19-0094

Baseline demographics and clinical characteristics in the all nippon af in the elderly (ANAFIE) registry. / Koretsune, Yukihiro; Yamashita, Takeshi; Akao, Masaharu; Atarashi, Hirotsugu; Ikeda, Takanori; Okumura, Ken; Shimizu, Wataru; Tsutsui, Hiroyuki; Toyoda, Kazunori; Hirayama, Atsushi; Yasaka, Masahiro; Yamaguchi, Takenori; Teramukai, Satoshi; Kimura, Tetsuya; Kaburagi, Jumpei; Takita, Atsushi; Inoue, Hiroshi.

In: Circulation Journal, Vol. 83, No. 7, 01.01.2019, p. 1538-1545.

Research output: Contribution to journalArticle

Koretsune, Y, Yamashita, T, Akao, M, Atarashi, H, Ikeda, T, Okumura, K, Shimizu, W, Tsutsui, H, Toyoda, K, Hirayama, A, Yasaka, M, Yamaguchi, T, Teramukai, S, Kimura, T, Kaburagi, J, Takita, A & Inoue, H 2019, 'Baseline demographics and clinical characteristics in the all nippon af in the elderly (ANAFIE) registry', Circulation Journal, vol. 83, no. 7, pp. 1538-1545. https://doi.org/10.1253/circj.CJ-19-0094
Koretsune, Yukihiro ; Yamashita, Takeshi ; Akao, Masaharu ; Atarashi, Hirotsugu ; Ikeda, Takanori ; Okumura, Ken ; Shimizu, Wataru ; Tsutsui, Hiroyuki ; Toyoda, Kazunori ; Hirayama, Atsushi ; Yasaka, Masahiro ; Yamaguchi, Takenori ; Teramukai, Satoshi ; Kimura, Tetsuya ; Kaburagi, Jumpei ; Takita, Atsushi ; Inoue, Hiroshi. / Baseline demographics and clinical characteristics in the all nippon af in the elderly (ANAFIE) registry. In: Circulation Journal. 2019 ; Vol. 83, No. 7. pp. 1538-1545.
@article{30111a767e4348e280bf01fb9e0efc9c,
title = "Baseline demographics and clinical characteristics in the all nippon af in the elderly (ANAFIE) registry",
abstract = "Background: Despite the well-established benefits in patients with nonvalvular atrial fibrillation (NVAF), anticoagulants have been underused in elderly patients. The All Nippon AF In the Elderly (ANAFIE) Registry is a multicenter, prospective, observational study with 2-year follow-up of Japanese patients aged ≥75 years with a definitive diagnosis of NVAF, aiming to collect detailed information on clinical status and therapeutic challenges in this patient population. Methods and Results: Patients were enrolled from October 2016 to January 2018. A total of 32,726 patients (57.2{\%} male) were included. The average age, CHADS2 score, and creatinine clearance were 81.5±4.8 years (26.2{\%} of patients were aged ≥85 years), 2.9±1.2, and 48.4±21.8 mL/min, respectively. Paroxysmal AF was the most common clinical AF type (42.0{\%}), and most patients (97.2{\%}) had comorbidities. Most patients (91.9{\%}) were receiving anticoagulant therapy; of these, 27.8{\%} and 72.2{\%} were treated with warfarin and direct oral anticoagulants, respectively. The average number of concomitant drugs used was 6.6±3.2, including anticoagulants. Conclusions: The ANAFIE Registry is the largest prospective registry study of elderly Japanese patients with NVAF to date. Baseline data indicate that patients in this age group are treated in a manner similar to their younger counterparts.",
author = "Yukihiro Koretsune and Takeshi Yamashita and Masaharu Akao and Hirotsugu Atarashi and Takanori Ikeda and Ken Okumura and Wataru Shimizu and Hiroyuki Tsutsui and Kazunori Toyoda and Atsushi Hirayama and Masahiro Yasaka and Takenori Yamaguchi and Satoshi Teramukai and Tetsuya Kimura and Jumpei Kaburagi and Atsushi Takita and Hiroshi Inoue",
year = "2019",
month = "1",
day = "1",
doi = "10.1253/circj.CJ-19-0094",
language = "English",
volume = "83",
pages = "1538--1545",
journal = "Circulation Journal",
issn = "1346-9843",
publisher = "Japanese Circulation Society",
number = "7",

}

TY - JOUR

T1 - Baseline demographics and clinical characteristics in the all nippon af in the elderly (ANAFIE) registry

AU - Koretsune, Yukihiro

AU - Yamashita, Takeshi

AU - Akao, Masaharu

AU - Atarashi, Hirotsugu

AU - Ikeda, Takanori

AU - Okumura, Ken

AU - Shimizu, Wataru

AU - Tsutsui, Hiroyuki

AU - Toyoda, Kazunori

AU - Hirayama, Atsushi

AU - Yasaka, Masahiro

AU - Yamaguchi, Takenori

AU - Teramukai, Satoshi

AU - Kimura, Tetsuya

AU - Kaburagi, Jumpei

AU - Takita, Atsushi

AU - Inoue, Hiroshi

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Despite the well-established benefits in patients with nonvalvular atrial fibrillation (NVAF), anticoagulants have been underused in elderly patients. The All Nippon AF In the Elderly (ANAFIE) Registry is a multicenter, prospective, observational study with 2-year follow-up of Japanese patients aged ≥75 years with a definitive diagnosis of NVAF, aiming to collect detailed information on clinical status and therapeutic challenges in this patient population. Methods and Results: Patients were enrolled from October 2016 to January 2018. A total of 32,726 patients (57.2% male) were included. The average age, CHADS2 score, and creatinine clearance were 81.5±4.8 years (26.2% of patients were aged ≥85 years), 2.9±1.2, and 48.4±21.8 mL/min, respectively. Paroxysmal AF was the most common clinical AF type (42.0%), and most patients (97.2%) had comorbidities. Most patients (91.9%) were receiving anticoagulant therapy; of these, 27.8% and 72.2% were treated with warfarin and direct oral anticoagulants, respectively. The average number of concomitant drugs used was 6.6±3.2, including anticoagulants. Conclusions: The ANAFIE Registry is the largest prospective registry study of elderly Japanese patients with NVAF to date. Baseline data indicate that patients in this age group are treated in a manner similar to their younger counterparts.

AB - Background: Despite the well-established benefits in patients with nonvalvular atrial fibrillation (NVAF), anticoagulants have been underused in elderly patients. The All Nippon AF In the Elderly (ANAFIE) Registry is a multicenter, prospective, observational study with 2-year follow-up of Japanese patients aged ≥75 years with a definitive diagnosis of NVAF, aiming to collect detailed information on clinical status and therapeutic challenges in this patient population. Methods and Results: Patients were enrolled from October 2016 to January 2018. A total of 32,726 patients (57.2% male) were included. The average age, CHADS2 score, and creatinine clearance were 81.5±4.8 years (26.2% of patients were aged ≥85 years), 2.9±1.2, and 48.4±21.8 mL/min, respectively. Paroxysmal AF was the most common clinical AF type (42.0%), and most patients (97.2%) had comorbidities. Most patients (91.9%) were receiving anticoagulant therapy; of these, 27.8% and 72.2% were treated with warfarin and direct oral anticoagulants, respectively. The average number of concomitant drugs used was 6.6±3.2, including anticoagulants. Conclusions: The ANAFIE Registry is the largest prospective registry study of elderly Japanese patients with NVAF to date. Baseline data indicate that patients in this age group are treated in a manner similar to their younger counterparts.

UR - http://www.scopus.com/inward/record.url?scp=85068605630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068605630&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-19-0094

DO - 10.1253/circj.CJ-19-0094

M3 - Article

VL - 83

SP - 1538

EP - 1545

JO - Circulation Journal

JF - Circulation Journal

SN - 1346-9843

IS - 7

ER -